NCT06966973

Brief Summary

Laboratory polysomnography is the gold standard for objective sleep measurement. With hospital waiting times becoming increasingly long, outpatient polysomnography seems a good solution. Children are at greater risk of developing sleep disorders and polysomnography in the hospital laboratory can be a stressful examination for these children and their parents. This can be even more the case in populations of children with neurodevelopmental disorders, such as Attention Deficit Disorder with or without Hyperactivity (ADHD), or dys- learning disorders. Several studies have already demonstrated the feasibility of ambulatory, in a home setting, polysomnography in children. The objective of this study is to demonstrate the acceptability and satisfaction of performing polysomnography at home on a large cohort of children, including children with neurodevelopmental disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
563

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 13, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

5.2 years

First QC Date

March 13, 2025

Last Update Submit

May 2, 2025

Conditions

Keywords

Home unattended polysomnographyAttention deficit disorderAttention deficit hyperactivity disorderLearning disorders

Outcome Measures

Primary Outcomes (1)

  • Acceptability of Home Unattended Polysomnography

    Parents and children completed 10 cm visual analog scales (VAS) to assess their satisfaction with the home recording (scored from 0 (not enjoyed) to 10 (very satisfied) and preference for home versus laboratory PSG (scored from 0 preference for H-PSG to 10 preference for L-PSG).

    One day after the polysomnography

Secondary Outcomes (12)

  • List of symptoms prompting polysomnographic examination

    During the polysomnography analysis

  • Global signal quality across all channels of the polysomnographic recording.

    One night of polysomnography.

  • SpO₂ signal quality of the polysomnographic recording.

    One night of polysomnography.

  • Nasal cannula signal quality of the polysomnography recording.

    One night of polysomnography.

  • RIP (Respiratory Inductance Plethysmography) quality of the polysomnography recording.

    One night of polysomnography.

  • +7 more secondary outcomes

Study Arms (1)

All children aged 2 to 17

Other: Polysomnograpy

Interventions

All successive patients who underwent polysomnography

All children aged 2 to 17

Eligibility Criteria

Age2 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population consisted of any children coming to the doctor's office for a home unattended polysomnography, aged between 2 and 17 years at the time of polysomnography, and whose parents had signed a consent form for polysomnography and data collection.

You may qualify if:

  • All consecutive children who underwent a H-PSH
  • Age beetween 2 and 17 years old

You may not qualify if:

  • No signed informed consent form for study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPNOS

Garches, 92380, France

Location

Related Links

MeSH Terms

Conditions

Neurodevelopmental DisordersNocturnal Myoclonus SyndromeAttention Deficit Disorder with HyperactivityLearning Disabilities

Condition Hierarchy (Ancestors)

Mental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesParasomniasAttention Deficit and Disruptive Behavior DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2025

First Posted

May 13, 2025

Study Start

January 1, 2018

Primary Completion

February 28, 2023

Study Completion

September 30, 2024

Last Updated

May 13, 2025

Record last verified: 2025-05

Locations